Oxurion secures major funding for cryptocurrency investments

Oxurion NV, a pharmaceutical contract manufacturing organization based in Leuven, has announced €30 million in funding to invest in digital assets. This sum, obtained through an agreement with Atlas Capital Markets, is divided into 12 tranches of convertible bonds. The aim is to diversify Oxurion's assets by focusing on cryptocurrencies such as Bitcoin and Ethereum.

This financing is part of a long-term investment strategy aimed at strengthening Oxurion's position in the digital markets. The tranches will be released sequentially, contingent upon the conversion of previous bonds. A first-lien lien is secured against the digital assets to guarantee these transactions.